Biosurgery Market Overview

The global biosurgery market is experiencing transformative growth, driven by rising surgical volumes, increasing awareness of advanced hemostatic solutions, and growing demand for products that minimize intraoperative blood loss. Biosurgery refers to the application of biological materials and technologies in surgical settings to manage bleeding, seal tissues, and promote healing. According to Expert Market Research, the biosurgery market size attained a value of USD 16.55 Billion in 2025, with projections indicating it will nearly double to reach USD 33.17 Billion by 2035, growing at a robust CAGR of 7.20% during the forecast period of 2026–2035.

This rapid expansion reflects the critical role that biosurgery products now play across a wide spectrum of surgical disciplines  from orthopaedic and cardiovascular procedures to neurological and gynaecological surgeries. As hospitals and surgical centers continue to prioritize patient safety and procedural efficiency, the biosurgery market share continues to grow, opening new avenues for innovation and investment.

Biosurgery Market Size and Share Understanding the Numbers

The biosurgery market size and share data paints a compelling picture for investors, healthcare providers, and medical device manufacturers alike. According to Expert Market Research, the market stood at USD 16.55 Billion in 2025 and is set to reach USD 33.17 Billion by 2035 at a CAGR of 7.20%. This trajectory underscores the increasing integration of biosurgical products into standard surgical protocols worldwide.

North America currently holds the largest biosurgery market share, owing to its advanced healthcare infrastructure, higher surgical procedure volumes, and greater adoption of innovative medical technologies. Europe follows closely, while the Asia Pacific region is emerging as the fastest-growing market, fueled by improving healthcare access, rising medical tourism, and expanding hospital networks in countries like China, India, and South Korea.

Key Biosurgery Market Trends Shaping the Industry in 2025 and Beyond

Several critical trends are reshaping the biosurgery market landscape. Expert Market Research identifies the following as the most impactful forces driving change:

• Biosurgery Market Shift Toward Minimally Invasive Procedures: Growing preference for laparoscopic and robotic-assisted surgeries is driving demand for specialized hemostatic and sealing products compatible with minimally invasive techniques.
• Rising Chronic Disease Burden: Increased incidence of cardiovascular diseases, bone disorders, and cancer is leading to more surgeries, thereby boosting biosurgery market demand across multiple segments.
• Technological Innovation in Surgical Sealants and Adhesives: Advanced formulations offering faster sealing, improved biocompatibility, and reduced post-surgical complications are gaining traction globally.
• Expansion of Biologics in Surgical Settings: The use of biologically derived agents such as fibrin sealants and collagen-based hemostats is growing, driven by superior clinical outcomes compared to synthetic alternatives.
• Growing Geriatric Population: An aging global population requires more surgical interventions, particularly in orthopaedics and cardiovascular care, directly amplifying biosurgery market size.
• Increased R&D Spending by Key Players: Major companies are investing heavily in developing next-generation biosurgery products that reduce operative time and improve recovery rates.
• Regulatory Approvals Boosting Market Confidence: Streamlined regulatory pathways in the U.S., Europe, and Asia are facilitating faster product launches, accelerating biosurgery market share growth.
• Healthcare Infrastructure Development in Emerging Markets: Countries in Latin America, the Middle East, and Africa are investing in hospital infrastructure and surgical training, expanding the biosurgery market footprint.

Get a free request sample report

Biosurgery Market Segmentation by Product: What Drives Revenue?

The biosurgery market encompasses a diverse range of product categories, each addressing specific surgical needs. Based on product type, the market is segmented into the following categories:

Bone-Graft Substitutes

These materials are used to fill bone defects or enhance bone regeneration in orthopaedic and spinal surgeries. Increasing incidences of fractures, spinal disorders, and joint replacements are fueling demand in this segment.

Soft-Tissue Attachments

Used to repair or reinforce soft tissues, these products are critical in hernia repairs, abdominal surgeries, and reconstructive procedures.

Haemostatic Agents

One of the largest and fastest-growing segments, haemostatic agents control bleeding during surgery and are indispensable in complex cardiovascular and trauma surgeries.

Surgical Sealants and Adhesives

These products offer superior tissue sealing capabilities, reducing leakage and complications in procedures involving the lungs, heart, and gastrointestinal tract.

Adhesion Barriers

Used post-surgery to prevent the formation of fibrous bands between tissues, adhesion barriers are particularly vital in gynaecological and abdominal surgeries.

Staple Line Reinforcement

Critical in bariatric and thoracic surgeries, these materials reduce the risk of leaks along stapled tissue margins.

Biosurgery Market by Application: Where Is the Demand Highest?

The biosurgery market's application landscape spans multiple surgical specialties. Orthopaedic surgery accounts for a substantial portion of market demand, driven by the rising prevalence of bone and joint disorders globally. General surgery remains one of the most active application segments, encompassing a wide range of abdominal, laparoscopic, and gastrointestinal procedures. Neurological surgery increasingly relies on advanced sealants and haemostatic agents to manage delicate brain and spinal operations. Cardiovascular surgery is another high-volume segment where biosurgery products are essential to minimize blood loss and complications. Gynaecological surgery and other emerging surgical disciplines continue to contribute to the biosurgery market's diversified growth profile.

Regional Analysis Which Markets Are Leading Biosurgery Growth?

The biosurgery market demonstrates distinct growth patterns across regions. North America leads in both biosurgery market size and innovation, supported by high surgical procedure volumes and significant healthcare investments. Europe maintains a strong market position, with countries such as Germany, France, and the U.K. at the forefront of adopting biosurgical technologies. Asia Pacific is witnessing the fastest growth, driven by rapid healthcare modernization, rising disposable incomes, and expanding surgical centers in China, India, and Southeast Asia. Latin America and the Middle East & Africa are emerging markets, increasingly adopting biosurgery products as healthcare infrastructure develops and surgical volumes rise.

Competitive Landscape Key Companies in the Biosurgery Market

The biosurgery market is highly competitive, with leading global players continuously innovating to strengthen their market positions. According to Expert Market Research, the key companies shaping this market include:

• Baxter – A global leader in hemostatic products and surgical sealants.
• BD (Becton, Dickinson and Company) – Known for a wide portfolio of surgical and vascular products.
• Johnson & Johnson Services, Inc. – Offers a comprehensive range of biosurgery solutions across multiple surgical categories.
• Medtronic – A pioneer in minimally invasive surgical technologies and biosurgical products.
• Braun Melsungen AG – Specializes in infusion therapy and wound care biosurgery solutions.
• CryoLife, Inc. – Focuses on cardiac and vascular surgery biosurgery products.
• Stryker Corporation – A key player in orthopaedic biosurgery and bone-graft substitutes.
• Integra LifeSciences Corporation – Renowned for regenerative medicine and neurosurgical biosurgery products.
• Hemostasis, LLC – Specializes in hemostatic agents for various surgical applications.
• CSL Limited – Offers plasma-based biosurgery products including surgical sealants.
• AROA BIOSURGERY LIMITED – Focused on soft-tissue repair and regeneration.
• TELA Bio, Inc. – Innovator in OviTex reinforced tissue matrices for hernia repair.
• Tissue Regenix – Develops decellularized biological scaffolds for tissue repair.
• Osiris Therapeutics, Inc. – Pioneer in regenerative medicine and stem cell-based therapies.

About Expert Market Research and the Biosurgery Market Report

Expert Market Research is a leading global market intelligence firm providing comprehensive data, forecasts, and strategic insights across industries. The biosurgery market report from Expert Market Research offers in-depth analysis of market size, share, growth drivers, segmentation, regional dynamics, and competitive landscape. Expert Market Research has identified the biosurgery market as one of the most promising sectors in the global medical devices industry, with significant opportunities emerging across product categories and geographies. The research methodology employed by Expert Market Research ensures accuracy, reliability, and actionable intelligence for stakeholders including manufacturers, investors, and healthcare policymakers. For those seeking detailed quantitative and qualitative biosurgery market intelligence, Expert Market Research remains the definitive source.

Frequently Asked Questions (FAQs)

• What is the current size of the biosurgery market?

The global biosurgery market size reached USD 16.55 Billion in 2025 and is projected to grow at a CAGR of 7.20% to attain USD 33.17 Billion by 2035, according to Expert Market Research.

2. What is the biosurgery market share by region?

North America holds the largest biosurgery market share globally, followed by Europe. The Asia Pacific region is the fastest-growing market, driven by healthcare expansion and rising surgical volumes.

3. What are the main product segments in biosurgery?

Key product segments include Bone-Graft Substitutes, Soft-Tissue Attachments, Haemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, and Staple Line Reinforcement.

4. Which companies are the major players in this market?

Leading companies include Baxter, BD, Johnson & Johnson, Medtronic, B. Braun Melsungen AG, CryoLife, Stryker Corporation, Integra LifeSciences, and others.

5. What are the primary drivers of biosurgery market growth?

The key growth drivers include rising surgical procedure volumes, increasing prevalence of chronic diseases, aging populations, technological innovation in hemostatic agents and sealants, and expanding healthcare infrastructure in emerging markets.

Read More Insights

Video Surveillance Storage Market

Seeds Market

Trash Bags Market

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

Media Contact

Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com